New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review

References

• World Health Organization. Noncommunicable diseases: key facts [website]. 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed November 27, 2019.
   Google Scholar
• Ricardo CZ, Azeredo CM, Machado de Rezende LF, Levy RB. Co-occurrence and clustering of the four major non-communicable disease risk factors in Brazilian adolescents: analysis of a national school-based survey. PLoS One. 2019;14(7):e0219370. doi:10.1371/journal.pone.0219370
   PubMed Web of Science ®Google Scholar
• World Health Organization. Noncommunicable diseases (NCD) country profiles [website]. 2018. Available from: https://www.who.int/publications/i/item/ncd-country-profiles-2018. Accessed August 7, 2020.
   Google Scholar
• Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff (Millwood). 2009;28(1):64–74. doi:10.1377/hlthaff.28.1.64
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020 [website]. 2020. Available from: https://apps.who.int/iris/handle/10665/274512. Accessed August 7, 2020.
   Google Scholar
• ISPOR. Medication adherence and persistence, special interest group [website]. 2021. Available from: https://www.ispor.org/member-groups/special-interest-groups/medication-adherence-and-persistence. Accessed August 7, 2020.
   Google Scholar
• World Health Organization. COVID-19 dashboard [website]. 2020. Available from: https://covid19.who.int/. Accessed October 15, 2020.
   Google Scholar
• Azarpazhooh MR, Morovatdar N, Avan A, et al. COVID-19 pandemic and burden of non-communicable diseases: an ecological study on data of 185 countries. J Stroke Cerebrovasc Dis. 2020;29(9):105089. doi:10.1016/j.jstrokecerebrovasdis.2020.105089
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985
   PubMed Web of Science ®Google Scholar
• Hassan TA, Enrique Saenz J, Li JZ, Ducinskiene D, Imperato J, Zou KH. A confluence of acute and chronic diseases: risk factors among Covid-19 patients. Significance Magazine. 2020.
   Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776. doi:10.1001/jama.2020.4683
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743–744. doi:10.1001/jamacardio.2020.0934
   PubMed Web of Science ®Google Scholar
• Bergman M, Jagannathan R, Narayan KMV. Nexus of COVID-19 and diabetes pandemics: global public health lessons. Diabetes Res Clin Pract. 2020;164:108215. doi:10.1016/j.diabres.2020.108215
   Web of Science ®Google Scholar
• Hernandez-Galdamez DR, Gonzalez-Block MA, Romo-Duenas DK, et al. Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res. 2020;51(7):683–689. doi:10.1016/j.arcmed.2020.07.003
   PubMed Web of Science ®Google Scholar
• Zali A, Gholamzadeh S, Mohammadi G, et al. Baseline characteristics and associated factors of mortality in COVID-19 patients; an analysis of 16000 cases in Tehran, Iran. Arch Acad Emerg Med. 2020;8(1):e70.
   PubMedGoogle Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using openSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
   PubMed Web of Science ®Google Scholar
• Iftimie S, Lopez-Azcona AF, Vicente-Miralles M, et al. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PLoS One. 2020;15(9):e0234452. doi:10.1371/journal.pone.0234452
   PubMed Web of Science ®Google Scholar
• World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment [website]. 2020. Available from: https://www.who.int/publications/i/item/ncds-covid-rapid-assessment. Accessed December 18, 2020.
   Google Scholar
• Hariyanto TI, Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med. 2020;19:100290. doi:10.1016/j.obmed.2020.100290
   Google Scholar
• Zhang XJ, Qin JJ, Cheng X, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Metab. 2020;32(2):176–187. doi:10.1016/j.cmet.2020.06.015
   PubMed Web of Science ®Google Scholar
• Zhu L, She ZG, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077. doi:10.1016/j.cmet.2020.04.021
   PubMed Web of Science ®Google Scholar
• Ran J, Song Y, Zhuang Z, et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res. 2020;43(11):1267–1276. doi:10.1038/s41440-020-00541-w
   PubMed Web of Science ®Google Scholar
• Kayhan Tetik B, Gedik Tekinemre I, Tas S. The effect of the COVID-19 pandemic on smoking cessation success. J Community Health. 2021;46(3):471-475..
   Web of Science ®Google Scholar
• Marmot M, Bell R. Social determinants and non-communicable diseases: time for integrated action. BMJ. 2019;364:l251. doi:10.1136/bmj.l251
   PubMed Web of Science ®Google Scholar
• Murray CJ, Kulkarni S, Ezzati M. Eight Americas: new perspectives on U.S. health disparities. Am J Prev Med. 2005;29(5 Suppl 1):4–10. doi:10.1016/j.amepre.2005.07.031
   PubMed Web of Science ®Google Scholar
• Brunt H, Barnes J, Jones SJ, Longhurst JWS, Scally G, Hayes E. Air pollution, deprivation and health: understanding relationships to add value to local air quality management policy and practice in Wales, UK. J Public Health (Oxf). 2017;39(3):485–497. doi:10.1093/pubmed/fdw084
   Web of Science ®Google Scholar
• Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659–661. doi:10.1016/S2213-2600(20)30234-4
   PubMed Web of Science ®Google Scholar
• Patel AP, Paranjpe MD, Kathiresan NP, Rivas MA, Khera AV. Race, socioeconomic deprivation, and hospitalization for COVID-19 in English participants of a national biobank. Int J Equity Health. 2020;19(1):114. doi:10.1186/s12939-020-01227-y
   PubMed Web of Science ®Google Scholar
• Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891–1892. doi:10.1001/jama.2020.6548
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47. doi:10.1111/j.1524-4733.2007.00213.x
   PubMed Web of Science ®Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159. doi:10.5001/omj.2011.38
   PubMedGoogle Scholar
• Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007;20(1):72–80. doi:10.3122/jabfm.2007.01.060094
   PubMed Web of Science ®Google Scholar
• Dube C. Concordance: a partnership in medicine‐taking. Health Expect. 2010;13(1):108–110. doi:10.1111/j.1369-7625.2008.00526.x
   Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies [website]. 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed July 21, 2021.
   Google Scholar
• Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147–1152. doi:10.1001/archinte.165.10.1147
   PubMedGoogle Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.1836
   PubMed Web of Science ®Google Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–779. doi:10.1016/j.ahj.2007.12.011
   PubMed Web of Science ®Google Scholar
• Ofori-Asenso R, Sahle BW, Chin KL, et al. Poor adherence and persistence to sodium glucose co-transporter 2 inhibitors in real-world settings: evidence from a systematic review and meta-analysis. Diabetes Metab Res Rev. 2021;37:e3350. doi:10.1002/dmrr.3350
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. doi:10.1097/01.mlr.0000114908.90348.f9
   PubMed Web of Science ®Google Scholar
• Ofori-Asenso R, Jakhu A, Zomer E, et al. Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2018;73(6):813–819. doi:10.1093/gerona/glx169
   Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Khan R, Socha-Dietrich K. Investigating in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidemia. OECD Health Working Papers No 105. 2018.
   Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:10.2147/RMHP.S19801
   PubMedGoogle Scholar
• Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795. doi:10.7326/0003-4819-157-11-201212040-00538
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Alfian SD, Sukandar H, Lestari K, Abdulah R. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther. 2016;7(4):755–764. doi:10.1007/s13300-016-0203-x
   Web of Science ®Google Scholar
• Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014;33(8):1444–1452. doi:10.1377/hlthaff.2013.1398
   PubMed Web of Science ®Google Scholar
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:10.3389/fphar.2013.00091
   PubMed Web of Science ®Google Scholar
• Adella Halim D, Kurniawan A, Agung FH, et al. Understanding of young people about COVID-19 during early outbreak in Indonesia. Asia Pac J Public Health. 2020;32(6–7):363–365. doi:10.1177/1010539520940933
   PubMed Web of Science ®Google Scholar
• Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007;44(8):1468–1477. doi:10.1016/j.ijnurstu.2006.07.010
   PubMed Web of Science ®Google Scholar
• Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–896. doi:10.1016/j.amjmed.2012.01.003
   Web of Science ®Google Scholar
• Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18(1):5. doi:10.1186/s12916-019-1474-7
   PubMed Web of Science ®Google Scholar
• Keenan J. Improving adherence to medication for secondary cardiovascular disease prevention. Eur J Prev Cardiol. 2017;24(3_suppl):29–35. doi:10.1177/2047487317708145
   Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
   PubMed Web of Science ®Google Scholar
• US Food & Drug Administration. Pfizer-BioNTech COVID-19 vaccine - emergency use authorization [website]. 2020. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine. Accessed December 13, 2020.
   Google Scholar
• Medicines & Healthcare Products Regulatory Agency. Decision: conditions of authorisation for Pfizer/BioNTech COVID-19 vaccine [website]. 2020. Available from: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine. Accessed December 13, 2020.
   Google Scholar
• Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424. doi:10.1016/j.ahj.2011.06.007
   PubMed Web of Science ®Google Scholar
• Neiman AB, Ruppar T, Ho M, et al. CDC Grand Rounds: improving medication adherence for chronic disease management - innovations and opportunities. MMWR Morb Mortal Wkly Rep. 2017;66(45):1248–1251. doi:10.15585/mmwr.mm6645a2
   Web of Science ®Google Scholar
• Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–562. doi:10.1007/s40265-013-0041-3
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality (AHRQ). Organizing quality measures by domains of health care quality [website]. 2016. Available from: https://www.ahrq.gov/talkingquality/translate/organize/quality-domain.html. Accessed November 3, 2020.
   Google Scholar
• Matulis JC, McCoy R. Patient-centered appointment scheduling: a call for autonomy, continuity, and creativity. J Gen Intern Med. 2021;36(2):511–514. doi:10.1007/s11606-020-06058-9
   Web of Science ®Google Scholar
• Yamane SS, De Gagne JC, Riggs A, Kimberly GD, Holye M. Assessment of a patient-centered initiative to improve hypertension management for adults with comorbid type 2 diabetes at a free clinic in the rural south. Nurs Forum. 2020;55(3):348–355. doi:10.1111/nuf.12434
   Web of Science ®Google Scholar
• Zou KH, Imperato J, Potkar CN, Sethi N, Edwards J, Ray A. Harnessing real-world data for regulatory use and applying innovative applications. J Multidiscip Healthc. 2020;13:671–679. doi:10.2147/JMDH.S262776
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and food and drug administration staff. Docket no. FDA-2016-D-2153 [website]. 2017. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices. Accessed February 5, 2020.
   Google Scholar
• US Food and Drug Administration. Framework for FDA’s real-world evidence program [website]. 2018. Available from: https://www.fda.gov/media/120060/download. Accessed November 21, 2019.
   Google Scholar
• US Food and Drug Administration. Real-world evidence [website]. 2019. Available from: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence. Accessed December 19, 2019.
   Google Scholar
• US Food and Drug Administration. Submitting documents using real-world data and real-world evidence to FDA for drugs and biologics: guidance for industry. Docket no. 2019-09529 [website]. Center for Drug Evaluation and Rresearch, Center for Biologics Evaluation and Research; 2019. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/submitting-documents-using-real-world-data-and-real-world-evidence-fda-drugs-and-biologics-guidance. Accessed February 5, 2020.
   Google Scholar
• European Medicines Agency. Regulatory perspective on real world evidence (RWE) in scientific advice. EMA human scientific committees’ working parties with patients’ and consumers’ organisations (PCWP) and healthcare professionals’ organisations (HCPWP) [website]. 2018. Available from: https://www.ema.europa.eu/en/documents/presentation/presentation-regulatory-perspective-real-world-evidence-rwe-scientific-advice-emas-pcwp-hcpwp-joint_en.pdf. Accessed December 19, 2019.
   Google Scholar
• Fralick M, Kesselheim AS, Avorn J, Schneeweiss S. Use of health care databases to support supplemental indications of approved medications. JAMA Intern Med. 2018;178(1):55–63. doi:10.1001/jamainternmed.2017.3919
   Web of Science ®Google Scholar
• Zou KH, Li JZ, Salem LA, Imperato J, Edwards J, Ray A. Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights. Health Serv Outcomes Res Methodol. 2020;1–13. doi:10.1007/s10742-020-00223-7
   Web of Science ®Google Scholar
• Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective. Clinicoecon Outcomes Res. 2018;10:359–370. doi:10.2147/CEOR.S165576
   Web of Science ®Google Scholar
• Garry EM, Schneeweiss S, Eapen S, et al. Actionable real-world evidence to improve health outcomes and reduce medical spending among risk-stratified patients with diabetes. J Manag Care Spec Pharm. 2019;25(12):1442–1452. doi:10.18553/jmcp.2019.25.12.1442
   PubMed Web of Science ®Google Scholar
• US Food & Drug Administration. Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions [website]. 2020. Available from: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence. Accessed December 14, 2020.
   Google Scholar
• Chen ST, Huang ST, Shau WY, et al. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan. BMC Cardiovasc Disord. 2019;19(1):62. doi:10.1186/s12872-019-1032-4
   PubMed Web of Science ®Google Scholar
• Abernethy AP. Advancing the science of real-world data to address the COVID-19 pandemic [website]. US Food & Drug Administration; 2020. Available from: https://www.fda.gov/science-research/fda-grand-rounds/advancing-science-real-world-data-address-covid-19-pandemic-09102020-09102020. Accessed December 14, 2020.
   Google Scholar
• Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) CDC COVID data tracker. United States COVID-19 cases and deaths by state [website]. 2020. Available from: https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days. Accessed December 15, 2020.
   Google Scholar
• Johns Hopkins University of Medicine Coronavirus Resource Center. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU) [website]. 2020. Available from: https://coronavirus.jhu.edu/map.html. Accessed December 15, 2020.
   Google Scholar
• Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther. 1991;13(4):489–495.
   Web of Science ®Google Scholar
• Deen TL, Fortney JC, Pyne JM. Relationship between satisfaction, patient-centered care, adherence and outcomes among patients in a collaborative care trial for depression. Adm Policy Ment Health. 2011;38(5):345–355. doi:10.1007/s10488-010-0322-z
   Web of Science ®Google Scholar
• Piette JD, Aikens JE, Trivedi R, et al. Depression self-management assistance using automated telephonic assessments and social support. Am J Manag Care. 2013;19(11):892–900.
   Web of Science ®Google Scholar
• World Health Organization. mHealth new horizons for health through mobile technologies [website]. 2011. Available from: https://www.who.int/goe/publications/goe_mhealth_web.pdf. Accessed January 27, 2021.
   Google Scholar
• Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27(6):957–962. doi:10.1093/jamia/ocaa067
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. President Trump announces lower out of pocket insulin costs for Medicare’s seniors [website]. CMS.gov; 2020. Available from: https://www.cms.gov/newsroom/press-releases/president-trump-announces-lower-out-pocket-insulin-costs-medicares-seniors. Accessed November 3, 2020.
   Google Scholar
• Ghosh A, Gupta R, Misra A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes Metab Syndr. 2020;14(4):273–276. doi:10.1016/j.dsx.2020.04.001
   PubMed Web of Science ®Google Scholar
• AETNA. Extra benefits for you: enhanced coverage includes free counseling, COVID-19 testing and prescription home delivery [website]. 2020. Available from: https://www.aetna.com/individuals-families/member-rights-resources/covid19/benefits.html. Accessed November 5, 2020.
   Google Scholar
• Gill LL. Paying for healthcare in the age of coronavirus [website]. 2020. Available from: https://www.consumerreports.org/healthcare-costs/paying-for-healthcare-in-the-age-of-coronavirus/. Accessed November 5, 2020.
   Google Scholar
• Queller D. Parachute Rx: peace of mind for uninsured Americans [website]. 2020. Available from: https://www.express-scripts.com/corporate/articles/parachute-rx-peace-mind-uninsured-americans. Accessed November 5, 2020.
   Google Scholar
• Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract. 2010;64(2):169–181. doi:10.1111/j.1742-1241.2009.02196.x
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ding X, Guo Y, et al. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: a prospective study. Epilepsy Behav. 2019;100(Pt A):106400. doi:10.1016/j.yebeh.2019.07.001
   Web of Science ®Google Scholar
• Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–193. doi:10.1001/jamainternmed.2013.12944
   PubMed Web of Science ®Google Scholar
• IQVIA. Harness the power of Real World Data [website]. 2021. Available from: https://www.iqvia.com/solutions/real-world-evidence/real-world-data-and-insights . Accessed July 20, 2021.
   Google Scholar
• World Health Organization. Noncommunicable diseases: Overview: [website] Available at: https:// www.who.int/health-topics/noncommunicable-diseases#tab=tab_1. Accessed, December 18, 2020
   Google Scholar
• World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013-2020 [website]. 2021. Avaliable from: https://www.who.int/publications/i/item/9789241506236. Accessed January 26, 2021.
   Google Scholar